Editor's Note: Mechanisms of Activity of the TORC1 Inhibitor Everolimus in Waldenstrom Macroglobulinemia

Clin Cancer Res. 2024 Feb 16;30(4):919. doi: 10.1158/1078-0432.CCR-24-0178.
No abstract available

Publication types

  • Published Erratum